Intracardiac Echocardiography and Intravascular Ultrasound Market Size

Intracardiac Echocardiography and Intravascular Ultrasound Market size exceeded USD 810 million in 2021 and is expected to register around 5% CAGR through 2028. Increasing preference for minimally invasive cardiac procedures is anticipated to strengthen the industry growth potential. Higher disease prevalence represents broader patient pool impelling the demand for procedures in Cath labs, thereby boosting the adoption of IVUS and ICE imaging modalities.

Furthermore, the market will foresee lucrative growth opportunities with continued innovations by market players to cater increasing procedural volume. Thus, the aforementioned factors present numerous growth opportunities and enhance the ICE and IVUS market demand.

The product demand for ICE and IVUS has experienced growth in 2021 with continuation of elective or non-emergent procedures. Resource management with planning has helped the market players to efficiently manage product distribution post COVID-19. Although, some countries are continuously witnessing increase in COVID-19, preventive strategies, maximized vaccination coverage and expansion of healthcare resources has minimized the intensity of negative impact on market sales in 2021.  Thus, the abovementioned factors favoured market growth during 2021 and the market is anticipated to foresee tremendous growth in the demand for ICE and IVUS technologies in future.

Intracardiac echocardiography (ICE) is considered as advanced imaging system, enabling physicians in high-resolution conception of cardiac tissues, real-time monitoring of catheter positioning and early identification of procedural difficulties. Whereas intravascular ultrasound (IVUS) makes use of transducer/probe to create sound waves and yield pictures of the internal structure of blood vessels.